Search

Your search keyword '"Libertinova, Jana"' showing total 2 results
Start Over Author "Libertinova, Jana" Publication Type Magazines
2 results on '"Libertinova, Jana"'

1. Is breastfeeding in MS harmful or not? An answer from real-world Czech data

Author

Hradilek, Pavel, Zapletalova, Olga, Hanulikova, Petra, Havrdova, Eva Kubala, Woznicova, Ivana, Mazouchova, Aneta, Drahota, Jiri, Lauer, Michal, Stetkarova, Ivana, Valis, Martin, Libertinova, Jana, Stourac, Pavel, Adamkova, Jana, Ampapa, Radek, Vachova, Marta, Dufek, Michal, Martinková, Alena, Peterka, Marek, Recmanova, Eva, Mares, Jan, and Horakova, Dana

Abstract

•This article brings original data describing MS disease activity parameters after delivery according to breastfeeding status in the population of Czech women with MS•The disease progression (EDSS), confirmed disease worsening (CDW) and relapses are evaluated at follow up periods•These parameters are correlated to the type of treatment prior to conception, age at conception, MS duration, relapse rate during pregnancy and EDSS before conception•We conclude that breastfeeding is generally safe in the population of Czech women and has no negative impact on the disease course at follow up.

Published
2023
Full Text
View/download PDF

2. Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Author

Hrnciarova, Tereza, Drahota, Jiri, Spelman, Tim, Hillert, Jan, Lycke, Jan, Havrdova, Eva Kubala, Recmanova, Eva, Adamkova, Jana, Mares, Jan, Libertinova, Jana, Pavelek, Zbysek, Hradilek, Pavel, Ampapa, Radek, Stetkarova, Ivana, Peterka, Marek, Martinkova, Alena, Stourac, Pavel, Grunermelova, Marketa, Vachova, Marta, Dufek, Michal, and Horakova, Dana

Abstract

•Direct initiation of moderate-high efficacy therapy seems beneficial•Moderate-high efficacy therapy does not lead to treatment switch due to adverse events•Treatment strategy between Sweden and the Czech Republic differ•Early moderate-high efficacy therapy initiation might lead to confirmed disability improvement

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results